Catheter Precision Inc (VTAK)
0.422
0.00 (0.00%)
USD |
NYAM |
Nov 22, 16:00
0.4146
-0.01
(-1.75%)
After-Hours: 20:00
Catheter Precision Cash from Financing (Quarterly): 4.02M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 4.02M |
June 30, 2024 | 0.267M |
March 31, 2024 | -0.11M |
December 31, 2023 | -0.107M |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.059M |
March 31, 2023 | 8.434M |
December 31, 2022 | 5.206M |
September 30, 2022 | 7.495M |
June 30, 2022 | -0.516M |
March 31, 2022 | 11.18M |
December 31, 2021 | 0.141M |
September 30, 2021 | 4.266M |
June 30, 2021 | 10.72M |
March 31, 2021 | -0.163M |
December 31, 2020 | -0.331M |
Date | Value |
---|---|
September 30, 2020 | 10.34M |
June 30, 2020 | 11.76M |
March 31, 2020 | -0.076M |
December 31, 2019 | -0.308M |
September 30, 2019 | -0.094M |
June 30, 2019 | -0.047M |
March 31, 2019 | -0.077M |
December 31, 2018 | 67.96M |
September 30, 2018 | -0.538M |
June 30, 2018 | 6.358M |
March 31, 2018 | 1.391M |
December 31, 2017 | 9.042M |
September 30, 2017 | 1.316M |
June 30, 2017 | 0.039M |
March 31, 2017 | -0.011M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.516M
Minimum
Jun 2022
11.76M
Maximum
Jun 2020
3.614M
Average
0.204M
Median
Cash from Financing (Quarterly) Benchmarks
Plus Therapeutics Inc | 0.00 |
Perspective Therapeutics Inc | 0.628M |
Retractable Technologies Inc | -0.1343M |
InfuSystems Holdings Inc | -6.752M |
Xtant Medical Holdings Inc | 5.314M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -2.768M |
Free Cash Flow | -8.381M |
Free Cash Flow Per Share (Quarterly) | -1.350 |
Free Cash Flow to Equity (Quarterly) | -3.867M |
Free Cash Flow Yield | -1.87K% |